NovoCure board seat vacated after Scannell retires
NovoCure said director Timothy Scannell retired from its board, with his seat vacated effective Sept. 2, 2026, in an 8-K filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.